Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pulmonary Hypertension in Adults With a Systemic Right Ventricle (Biventricular Circulation).

JACC. Advances·2026

Same author

Sports Cardiology Care in the United States: Can We Fix Fractured Cardiac Care?

JACC. Advances·2026

Same author

The kidney in the middle: Kidney Disease: Improving Global Outcomes (KDIGO) guidelines address multiple key components of cardiovascular-kidney-metabolic syndrome.

Kidney international·2026

Same author

Refining prognosis in advanced renal cell carcinoma: international real-world validation of the Meet-URO score in first-line immunotherapy combinations.

The oncologist·2026

Same author

Potential utility of prehospital blood for trauma patients in a dense, urban setting: simulations of prehospital travel times.

Proceedings (Baylor University. Medical Center)·2026

Same author

Obstructive Hypertrophic Cardiomyopathy in a Symptomatic Professional Athlete Treated With Mavacamten.

JACC. Case reports·2026

Search research articles

Related Experiment Video

Updated: May 7, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Mavacamten: Initial Insights From the Risk Evaluation and Mitigation Strategy Program

Matthew W Martinez¹, Dewey Seto², Michael Cheung²

¹Hypertrophic Cardiomyopathy Center, Morristown Medical Center, Atlantic Health System, Morristown, New Jersey, USA.

|December 30, 2024

Summary

No abstract available in PubMed .

Keywords:

hypertrophic cardiomyopathy left ventricular ejection fraction mavacamten obstructive HCM risk evaluation and mitigation strategy septal reduction therapy

More Related Videos

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method

Published on: June 7, 2018

Related Experiment Videos

Last Updated: May 7, 2025

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Comparing Metastatic Clear Cell Renal Cell Carcinoma Model Established in Mouse Kidney and on Chicken Chorioallantoic Membrane

Published on: February 8, 2020

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method

CMAP Scan MUNE MScan - A Novel Motor Unit Number Estimation MUNE Method

Published on: June 7, 2018